NASDAQ:BGMS
Bio Green Med Solution, Inc.
Bio Green Med Solution, Inc.'s revenue fell 100.0% in fiscal 2025 to $0. The diluted share count rose 9692.4%.Summary generated from Bio Green Med Solution, Inc.'s SEC filings. Latest annual report filed Mar 30, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growth−100.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−128.4%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+9692.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating income | −22 | −28 | −25 | −12 | −8 |
| Net income | −18 | −21 | −23 | −11 | −3 |
| Free cash flow | −19 | −21 | −16 | n/a | n/a |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KResults of operations and financial condition
Aug 14, 2026 - 8-KOther events
Jul 1, 2026 - 8-KResults of a shareholder vote
Jun 22, 2026 - 8-KEntry into a material agreement
Jun 10, 2026 - 8-KEntry into a material agreement
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 15, 2026 - 8-KResults of operations and financial condition
May 14, 2026